日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Long-Term Young Adult Cancer Survivors with Ovarian Cancer: Subgroup Analysis of the Study "Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer": The International NOGGO, ENGOT, and GCIG Survey

卵巢癌长期生存的年轻成人癌症幸存者：研究“Expression VI-Carolin Meets HANNA-Holistic Analysis of Long Term Survival with Oves Cancer”的亚组分析：国际NOGGO、ENGOT和GCIG调查

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18071183
Dimitrova, Desislava; Samartzis, Eleftherios Pierre; Zocholl, Dario; Barretina-Ginesta, Maria-Pilar; Leitner, Katharina; Havelka, Pavel; Achimas-Cadariu, Patriciu; Taskiran, Cagatay; Mittelstadt, Suzana; Van Nieuwenhuysen, Els; Bauerschmitz, Gerd; Heinzelmann-Schwarz, Viola; Madariaga, Ainhoa; Ringsdorf, Uta; Zwimpfer, Tibor; Madroñal, Caterina; Enzinger, Hans-Martin; Al Rubaish, Sara; Sehouli, Jalid; Woopen, Hannah
肿瘤
ENG
肿瘤免疫
卵巢癌
发表日期：2026
文献求助 收藏

Understanding Patients' Preferences for Discussing Sexuality After Surgery-A Qualitative Study of Sexuality and Body Image in Women with Ovarian Cancer

了解患者术后讨论性生活的偏好——一项关于卵巢癌女性性生活和身体形象的定性研究

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol33020110
Stöckl, Julia Rosa; Lee, Marlene M; Sehouli, Jalid; Pirmorady-Sehouli, Adak
肿瘤
肿瘤免疫
卵巢癌
发表日期：2026
文献求助 收藏

Characteristics and outcomes of patients with endometriosis and malignant or borderline ovarian tumors: real-world evidence from an ESGO centre of excellence

子宫内膜异位症合并恶性或交界性卵巢肿瘤患者的特征和预后：来自ESGO卓越中心的真实世界证据

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-026-15980-w
Beck, Maximilian Heinz; Kordowitzki, Paul; Roser, Eva; Trelinska-Finger, Anna; Schoof, Emily; Chinczewski, Lukas; Mechsner, Sylvia; Sehouli, Jalid
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer

DUO-E 研究结果的简明语言总结：度伐利尤单抗联合或不联合奥拉帕尼治疗晚期子宫内膜癌患者

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2026.2638677
Westin, Shannon N; Moore, Kathleen; Chon, Hye Sook; Lee, Jung-Yun; Thomes Pepin, Jessica; Sundborg, Michael; Shai, Ayelet; de la Garza, Joseph; Nishio, Shin; Gold, Michael A; Wang, Ke; McIntyre, Kristi; Tillmanns, Todd D; Blank, Stephanie V; Liu, Ji-Hong; McCollum, Michael; Contreras Mejia, Fernando; Nishikawa, Tadaaki; Pennington, Kathryn; Novak, Zoltan; De Melou, Andreia Cristina; Sehouli, Jalid; Klasa-Mazurkiewicz, Dagmara; Papadimitriou, Christos; Gil-Martin, Marta; Brasiuniene, Birute; Donnelly, Conor; Liu, Xiaochun; Nieuwenhuysen, Els Van
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Between research and introduction to clinical routine-Experience with niraparib from the compassionate use program in Germany (NOGGO Register Analysis)

从研究到临床常规应用——德国同情用药项目中尼拉帕尼的经验（NOGGO 注册分析）

期刊:Archives of Gynecology and Obstetrics
影响因子:2.5
doi:10.1007/s00404-025-08295-x
Grabowski, Jacek P; Welz, Julia; Heublein, Sabine; Krajewska, Maja; Boer, Jolijn D; Kraus, Fabian; Arndt, Tjadina; Moosmann, Nicolas; Heinrich, Bernhard; Engler, Tobias; Agabejli, Saida; Ugur, Mustafa Celalettin; Witteler, Ralf; Albrecht, Oliver; Müller-Huesmann, Harald; Oskay-Özcelik, Gülten; Hettwer, Cristina; Kaiser, Sabrina; Braicu, Elena; Sehouli, Jalid
发表日期：2026
文献求助 收藏

Characterization of exceptional responders with long-term PARP inhibitor therapy in recurrent ovarian cancer: an analysis of 23 patients from Charité

对接受长期 PARP 抑制剂治疗的复发性卵巢癌患者进行特征分析：来自柏林夏里特医院的 23 例患者的研究

期刊:Archives of Gynecology and Obstetrics
影响因子:2.5
doi:10.1007/s00404-026-08309-2
Glajzer, Jacek; Sehouli, Jalid; Woopen, Hannah; Braicu, Elena Ioana; Baum, Joanna; Grabowski, Jacek P
PARP
肿瘤
肿瘤免疫
卵巢癌
发表日期：2026
文献求助 收藏

Is pregnancy feasible in women with adult granulosa cell tumors, and how should recurrence during pregnancy be managed? A case report and literature review

成人型颗粒细胞瘤患者能否妊娠？妊娠期复发应如何处理？病例报告及文献综述

期刊:Gynecologic Oncology Reports
影响因子:1.3
doi:10.1016/j.gore.2026.102049
Matthaei, Moritz; Gebauer, B; Kunze, A; Schmitt, W; Dimitrova, D; Sehouli, J
细胞生物学
粒细胞
发表日期：2026
文献求助 收藏

Perioperative micro-arterial function and extravasation in cytoreductive ovarian cancer surgery: an observational study

卵巢癌减瘤手术中围手术期微动脉功能和渗漏：一项观察性研究

期刊:Intensive Care Medicine Experimental
影响因子:
doi:10.1186/s40635-025-00839-4
Feldheiser, Aarne; Dathe, Jana-Jennifer; Heinig, Sandra; Pietzner, Klaus; Kaufner, Lutz; Hunsicker, Oliver; von Haefen, Clarissa; Sehouli, Jalid; Spies, Claudia
肿瘤
肿瘤免疫
卵巢癌
发表日期：2026
文献求助 收藏

Transforming treatment paradigms: Focus on personalized medicine for high-grade serous ovarian cancer

转变治疗模式：聚焦高级别浆液性卵巢癌的个体化治疗

期刊:Ca-A Cancer Journal for Clinicians
影响因子:232.4
doi:10.3322/caac.70008
Kordowitzki, Pawel; Lange, Britta; Elias, Kevin M; Haigis, Marcia C; Mechsner, Sylvia; Braicu, Ioana Elena; Sehouli, Jalid
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Correction: ERRα promotes glycolytic metabolism and targets the NLRP3/caspase-1/GSDMD pathway to regulate pyroptosis in endometrial cancer

更正：ERRα促进糖酵解代谢，并靶向NLRP3/caspase-1/GSDMD通路以调节子宫内膜癌中的细胞焦亡。

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03292-z
Su, Pingping; Mao, Xiaodan; Ma, Jincheng; Huang, Lixiang; Yu, Lirui; Tang, Shuting; Zhuang, Mingzhi; Lu, Zhonglei; Osafo, Kelvin Stefan; Ren, Yuan; Wang, Xinrui; Lin, Xite; Huang, Leyi; Huang, Xiaoli; Braicu, Elena Ioana; Sehouli, Jalid; Sun, Pengming
肿瘤
子宫内膜癌
表观遗传
DMD
GSDMD
信号转导
肿瘤免疫
代谢
LRP3
焦亡
NLRP3
细胞生物学
发表日期：2025
文献求助 收藏